BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 28802661)

  • 21. Merkel cell carcinoma: an unusual indication for isolated limb perfusion.
    Ponte P; Moniz JV; Farricha V; Weinholtz JB
    Dermatol Online J; 2008 Jul; 14(7):6. PubMed ID: 18718190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.
    Eggermont AM; Schraffordt Koops H; Klausner JM; Kroon BB; Schlag PM; Liénard D; van Geel AN; Hoekstra HJ; Meller I; Nieweg OE; Kettelhack C; Ben-Ari G; Pector JC; Lejeune FJ
    Ann Surg; 1996 Dec; 224(6):756-64; discussion 764-5. PubMed ID: 8968230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study.
    Olieman AF; Liénard D; Eggermont AM; Kroon BB; Lejeune FJ; Hoekstra HJ; Koops HS
    Arch Surg; 1999 Mar; 134(3):303-7. PubMed ID: 10088573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma.
    Zogakis TG; Bartlett DL; Libutti SK; Liewehr DJ; Steinberg SM; Fraker DL; Alexander HR
    Ann Surg Oncol; 2001 Dec; 8(10):771-8. PubMed ID: 11776490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): A multicenter experience.
    van Veenendaal LM; Madu MF; Tesselaar MET; Verhoef C; Grünhagen DJ; van Akkooi ACJ
    Eur J Surg Oncol; 2017 Nov; 43(11):2157-2162. PubMed ID: 28802661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term response of isolated limb perfusion with hyperthermia and chemotherapy for Merkel cell carcinoma.
    Duprat JP; Domingues AL; Coelho EG; Leal RM; Nishinari K; Neves RI
    Eur J Surg Oncol; 2009 Jun; 35(6):568-72. PubMed ID: 19013049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated limb perfusion in Merkel cell carcinoma offers high rate of complete response and durable local-regional control: Systematic review and institutional experience.
    Thiels CA; Gonzalez AB; Gray RJ; Jakub JW
    J Surg Oncol; 2016 Aug; 114(2):187-92. PubMed ID: 27189050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-transit Merkel cell carcinoma treated with isolated limb perfusion or isolated limb infusion: a case series of 12 patients.
    Zeitouni NC; Giordano CN; Kane JM
    Dermatol Surg; 2011 Mar; 37(3):357-64. PubMed ID: 21324044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Merkel cell carcinoma: report of 10 cases and review of the literature.
    Akhtar S; Oza KK; Wright J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):755-67. PubMed ID: 11050578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs.
    Thompson JF; Gianoutsos MP
    World J Surg; 1992; 16(2):227-33. PubMed ID: 1561803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated limb perfusion for in-transit melanoma metastases: melphalan or TNF-melphalan perfusion?
    Hoekstra HJ; Veerman K; van Ginkel RJ
    J Surg Oncol; 2014 Mar; 109(4):338-47. PubMed ID: 24403098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases.
    Tai PT; Yu E; Winquist E; Hammond A; Stitt L; Tonita J; Gilchrist J
    J Clin Oncol; 2000 Jun; 18(12):2493-9. PubMed ID: 10856110
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.